Clinical Trial Update: Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anaerobic cultivated human intestinal microbiome transplantation for systemic sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Oslo University Hospital | Conditions: Systemic Sclerosis | Phase 2 | Status: COMPLETED